Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:1953-1954
Published online before print June 1, 2006, doi: 10.1161/01.STR.0000226905.99776.0d
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/7/1953    most recent
01.STR.0000226905.99776.0dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hankey, G. J.
Right arrow Articles by Schnabel, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hankey, G. J.
Right arrow Articles by Schnabel, A.
Related Collections
Right arrow Other Stroke Treatment - Medical

(Stroke. 2006;37:1953.)
© 2006 American Heart Association, Inc.


Cochrane Corner

Hyperbaric Oxygen Therapy for Acute Ischemic Stroke

Graeme J. Hankey, MD, FRCP, Section Editor:; Michael H. Bennett, FANZCA; Jason Wasiak, RN; Christopher French, FRACP; Peter Kranke, MBA Alexander Schnabel

From the Department of Diving and Hyperbaric Medicine (M.H.B.), Prince of Wales Hospital, Randwick, NSW, Australia; Burns, The Alfred Hospital Melbourne (J.W.), Australia; Department of Neurology (C.F.), Prince of Wales Hospital, Randwick, NSW, Australia; Department of Anesthesiology (P.K.), University Hospital Würzburg, Germany; and University of Würzburg (A.S.), Germany.

Correspondence to Michael H. Bennett, Prince of Wales Hospital, Barker St, Randwick, NSW 2031, Australia. E-mail m.bennett{at}unsw.edu.au


Key Words: brain infarction • hyperbaric oxygenation • meta-analysis


*    Introduction
up arrowTop
*Introduction
down arrowObjective
down arrowMethods
down arrowConclusions
down arrowReferences
 
During a stroke event, hypoxic changes can occur slowly enough in some patients to suggest that the close management of factors designed to maintain oxygenation might be beneficial. Intensive stroke management protocols and antiplatelet therapy have been established on this basis with some success. Hyperbaric oxygen therapy (HBOT) was first proposed as an adjunct in the treatment of ischemic stroke 40 years ago because of the ability of this therapy to deliver a greatly increased partial pressure of oxygen to the tissues.1

HBOT is the therapeutic administration of 100% oxygen at pressures >1 atmosphere (101.3 kPa). Typically, treatments involve pressurization to between 152 and 304 kPa for periods between 60 and 120 minutes daily. The potential benefits of HBOT include a reduction of cerebral edema, decreased lipid peroxidation, inhibition of leukocyte activation, and restoration of the functional blood–brain barrier.2,3 Conversely, oxygen in high doses may increase oxidative stress through the production of oxygen free-radical species, and the brain is particularly at risk.4


*    Objective
up arrowTop
up arrowIntroduction
*Objective
down arrowMethods
down arrowConclusions
down arrowReferences
 
The objective was to evaluate the effectiveness and safety of HBOT as an adjunctive therapy for the treatment of acute ischemic stroke.


*    Methods
up arrowTop
up arrowIntroduction
up arrowObjective
*Methods
down arrowConclusions
down arrowReferences
 
We performed a sensitive electronic search of multiple reference databases in late 2004, including Medline (Ovid), Cochrane Stroke Group Trials Registry, the Database of Randomized Controlled Trials in Diving and Hyperbaric Medicine,5 and EMBASE. The reference lists of retrieved articles were also searched for further clinical trials. No language restrictions applied. We included all randomized controlled trials that compared the effect of adjunctive HBOT with either no treatment or sham and in which death or functional scales were assessed as outcomes. Two authors using standardized forms extracted the data independently, and each included trial was assessed for internal validity with differences resolved by discussion.

Main Results
Three small randomized controlled trials (total 106 participants) were included in analysis. There were no statistically significant differences in mortality rate at 3 to 6 months in those receiving HBOT compared with control (relative risk, 0.61; 95% CI, 0.17 to 2.2; P=0.45; Figure). Two of 15 scale measures of disability or function indicated an improvement after HBOT, both at 1-year follow-up; the mean Trouillas Disability Scale was lower with HBOT (mean difference [MD] 2.2 points; 95% CI, 0.15 to 4.3; P=0.04), and the mean Orgogozo Scale was higher (MD, 27.9 points; 95% CI, 4.0 to 51.8; P=0.02). These improvements were not evident in previous assessments nor reflected in the other 13 functional scales recorded.


Figure 1
View larger version (11K):
[in this window]
[in a new window]
 
Death at 3 to 6 months after stroke. Relative risk of death 3 to 6 months after stroke with and without adjunctive HBOT.


*    Conclusions
up arrowTop
up arrowIntroduction
up arrowObjective
up arrowMethods
*Conclusions
down arrowReferences
 
Implications for Practice
In the 3 small trials published there is insufficient evidence to suggest that HBOT significantly affects outcome after acute ischemic stroke. The routine use of HBOT in stroke patients cannot be justified by this review.

Implications for Research
Given the small number of participants in the trials included, we cannot be certain that a benefit from HBOT has been excluded. Although there is a case for further trials, such investigations would need to be carefully planned. More information may be useful on a subset of disease severity and the timing of therapy. The effect of differing oxygen dosage and of other therapies administered simultaneously is not known.

Note: The full text, data tables, analyses, results, and reference list of this article are available in the Cochrane Library. The full text article should be cited as: Bennett MH, Wasiak J, Schnabel A, Kranke P, French C. Hyperbaric oxygen therapy for acute ischemic stroke. The Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD004954. DOI: 10.1002/14651858.CD004954.pub2.

The Cochrane Library is available at: http://www3. interscience.wiley.com/cgi-bin/mrwhome/106568753/HOME. Reprints of the full-text version are available online from this site.


*    Acknowledgments
 
The authors acknowledge the support and suggestions of Hazel Fraser and the editors of the Cochrane Stroke Group for their assistance in the preparation of this review. In particular, we acknowledge the help of Brenda Thomas with developing the search strategy used, and Daniel Rusyniak, Peter Langhorne, Ale Algra, and Steff Lewis for their editorial assistance.

Disclosures

None.

Received January 13, 2006; accepted January 24, 2006.


*    References
up arrowTop
up arrowIntroduction
up arrowObjective
up arrowMethods
up arrowConclusions
*References
 
1. Ingvar DH, Lassen NA. Treatment of focal cerebral ischemia with hyperbaric oxygen. Report of 4 cases. Acta Neurologica Scandinavica. 1965; 41: 92–95.[Medline] [Order article via Infotrieve]

2. Thom SR. Functional inhibition of leukocyte B2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicol Appl Pharmacol. 1993; 123: 248–256.[CrossRef][Medline] [Order article via Infotrieve]

3. Mink RB, Dutka AJ. Hyperbaric oxygen after global cerebral ischemia in rabbits reduces brain vascular permeability and blood flow. Stroke. 1995; 26: 2307–2312.[Abstract/Free Full Text]

4. Clark JM. Oxygen toxicity. In: Bennett PB, Elliott DH, eds. The Physiology and Medicine of Diving. 3rd ed. London, UK: Bailliere, Tindall, and Cox; 1982: 200–238.

5. Bennett MH, Connor D. The database of randomized controlled trials in diving and hyperbaric medicine. Available at: www.hboevidence.com. Accessed December 2005.




This article has been cited by other articles:


Home page
StrokeHome page
M. Bennett, J. Wasiak, C. French, P. Kranke, and A. Schnabel
Response to Letter by Helms et al
Stroke, April 1, 2007; 38(4): 1138 - 1139.
[Full Text] [PDF]


Home page
StrokeHome page
A. K. Helms, H. T. Whelan, and M. T. Torbey
Hyperbaric Oxygen Therapy of Acute Ischemic Stroke
Stroke, April 1, 2007; 38(4): 1137 - 1137.
[Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/7/1953    most recent
01.STR.0000226905.99776.0dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hankey, G. J.
Right arrow Articles by Schnabel, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hankey, G. J.
Right arrow Articles by Schnabel, A.
Related Collections
Right arrow Other Stroke Treatment - Medical